183666-09-3 Usage
General Description
Methyl 2-(3-nitro-2-oxopyridin-1(2H)-yl)acetate is a chemical compound that consists of a pyridine ring with a nitro group and a carbonyl group attached. It is commonly used in the synthesis of pharmaceuticals and agrochemicals. Methyl 2-(3-nitro-2-oxopyridin-1(2H)-yl)acetate has been found to exhibit antimicrobial and antioxidant properties, making it a potential candidate for the development of new drugs and agricultural products. Its chemical structure and properties make it a valuable building block in organic synthesis, and it is often used as an intermediate in the production of various chemical compounds. Additionally, this compound is also used as a flavoring agent and a fragrance ingredient in the food and cosmetic industries.
Check Digit Verification of cas no
The CAS Registry Mumber 183666-09-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,3,6,6 and 6 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 183666-09:
(8*1)+(7*8)+(6*3)+(5*6)+(4*6)+(3*6)+(2*0)+(1*9)=163
163 % 10 = 3
So 183666-09-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H8N2O5/c1-15-7(11)5-9-4-2-3-6(8(9)12)10(13)14/h2-4H,5H2,1H3
183666-09-3Relevant articles and documents
PYRIDAZINONE-BASED BROAD SPECTRUM ANTI-INFLUENZA INHIBITORS
-
Page/Page column 95, (2018/02/28)
The present invention relates to compounds of formula (I): (I) or pharmaceutically acceptable salts thereof, as well as processes for their manufacture, pharmaceutical compositions comprising them, and their use as medicaments.
Pyridone-based peptidomimetic inhibitors of interleukin-1β-converting enzyme (ICE)
Semple, Graeme,Ashworth, Doreen M.,Baker, Graham R.,Batt, Andrzej R.,Baxter, Andrew J.,Benzies, David W.M.,Elliot, Lucy H.,Evans, D. Michael,Franklin, Richard J.,Hudson, Peter,Jenkins, Paul D.,Pitt, Gary R.,Rooker, David P.,Sheppard, Andrew,Szelke, Michael,Yamamoto, Satoshi,Isomura, Yasuo
, p. 1337 - 1342 (2007/10/03)
New potent, reversible inhibitors of recombinant human Interleukin-1 β-converting enzyme (ICE, caspase-1) with significantly reduced peptide character are described. The compounds were designed by incorporation of pyridone and pyrimidone heterocyclic replacements for the P2-P3 amino acids of the native substrate and were optimised by manipulation of peripheral alkyl and aryl substituents.
